Randomised response-adaptive designs in clinical trials

Randomised Response-Adaptive Designs in Clinical Trials

Volumn , Issue , 2013, Pages 1-319

  Atkinson, Anthony C ^a   Biswas, Atanu ^b  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85054224274     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16101     Document Type: Book

References (295)

1. Andersen, J., D. Faries, and R. N. Tamura (1994). A randomized play-the-winner design for multi-arm clinical trials. Communications in Statistics-Theory and Methods 23, 309–323.
2. Anderson, W. J. (1991). Continuous Time Markov Chains. New York: Springer-Verlag.
3. Anisimov, V. V. and V. V. Fedorov (2007). Modelling, prediction and adaptive adjustment of recruitment in multicentre trials. Statistics in Medicine 26, 4958–4975.
4. Anscombe, F. (1963). Sequential medical trials. Journal of the American Statistical Association 58, 365–384.
5. Armitage, P. (1960). Sequential Medical Trials. Oxford: Blackwell.
6. Armitage, P. (1985). The search for optimality in clinical trials. International Statistical Review 53, 15–24.
7. Armitage, P., G. Berry, and J. N. S. Matthews (2004). Statistical Methods in Medical Research, 4th edn. Malden MA: Wiley-Blackwell.
8. Athreya, K. B. and S. Karlin (1968). Embedding of urn schemes into continuous time Markov branching processes and related limit theorems. Annals of Mathematical Statistics 39, 1801–1817.
9. Athreya, K. B. and P. E. Ney (1972). Branching Processes. Berlin: Springer-Verlag.
10. Atkinson, A. C. (1982). Optimum biased coin designs for sequential clinical trials with prognostic factors. Biometrika 69, 61–67.
11. Atkinson, A. C. (1999). Optimum biased-coin designs for sequential treatment allocation with covariate information. Statistics in Medicine 18, 1741–1752.
12. Atkinson, A. C. (2002). The comparison of designs for sequential clinical trials with covariate information. Journal of the Royal Statistical Society, Series A 165, 349–373.
13. Atkinson, A. C. (2003). The distribution of loss in two-treatment biased-coin designs. Biostatistics 4, 179–193.
14. Atkinson, A. C. (2012). Bias and loss: the two sides of a biased coin. Statistics in Medicine 31, 3494–3503.
15. Atkinson, A. C. (2014). Selecting a biased-coin design. Statistical Science 29. (In press).
16. Atkinson, A. C. and A. Biswas (2005a). Adaptive biased-coin designs for skewing the allocation proportion in clinical trials with normal responses. Statistics in Medicine 24, 2477–2492.
17. Atkinson, A. C. and A. Biswas (2005b). Bayesian adaptive biased-coin designs for clinical trials with normal responses. Biometrics 61, 118–125.
18. Atkinson, A. C. and A. Biswas (2014). Optimal doubly-adaptive designs for clinical trials with continuous multivariate or longitudinal responses. (Submitted).
19. Atkinson, A. C., A. Biswas, and L. Pronzato (2011). Covariate-balanced response-adaptive designs for clinical trials with continuous responses that target allocation probabilities. Technical Report NI11042-DAE, Isaac Newton Institute for Mathematical Sciences, Cambridge.
20. Atkinson, A. C., A. N. Donev, and R. D. Tobias (2007). Optimum Experimental Designs, with SAS. Oxford: Oxford University Press.
21. Atkinson, A. C. and M. Riani (2000). Robust Diagnostic Regression Analysis. New York: Springer–Verlag.
22. Bai, Z. D. and F. Hu (1999). Asymptotic theorems for urn models with non-homogeneous generating matrices. Stochastic Processes and Their Applications 80, 87–101.
23. Bai, Z. D., F. Hu, and W. F. Rosenberger (2002). Asymptotic properties of adaptive designs for clinical trials with delayed response. Annals of Statistics 30, 122–139.
24. Bai, Z. D., F. Hu, and L. Shen (2002). An adaptive design for multi-arm clinical trials. Journal of Multivariate Analysis 81, 1–18.
25. Bailey, R. A. and P. R. Nelson (2003). Hadamard randomization: a valid restriction of random permuted blocks. Biometrical Journal 45, 554– 560.
26. Baldi Antognini, A. (2004). Extensions of Ehrenfest’s urn designs for comparing two treatments. In A. Di. Bucchianico, H. Läuter, and H. P. Wynn (Eds.), mODa 7-Advances in Model-Oriented Design and Analysis, pp. 21–28. Heidelberg: Physica-Verlag.
27. Baldi Antognini, A. (2008). A theoretical analysis of the power of biased coin designs. Journal of Statistical Planning and Inference 138, 1792–1798.
28. Baldi Antognini, A. and A. Giovagnoli (2004). A new ‘biased coin design’ for the sequential allocation of two treatments. Applied Statistics 53, 651–664.
29. Baldi Antognini, A. and A. Giovagnoli (2005). On the large sample optimality of sequential designs for comparing two or more treatments. Sequential Analysis 24, 205–217.
30. Baldi Antognini, A. and A. Giovagnoli (2010). Compound optimal allocation for individual and collective ethics in binary clinical trials. Biometrika 97, 935–946.
31. Baldi Antognini, A. and M. Zagoraiou (2011). The covariate-adaptive biased coin design for balancing clinical trials in the presence of prognostic factors. Biometrika 98, 519–535.
32. Baldi Antognini, A. and M. Zagoraiou (2012). Multi-objective optimal designs in comparative clinical trials with covariates: the reinforced doubly adaptive biased coin designs. Annals of Statistics 40, 1315–1345.
33. Ball, F. G., A. F. M. Smith, and I. Verdinelli (1993). Biased coin designs with a Bayesian bias. Journal of Statistical Planning and Inference 34, 403–421.
34. Bandyopadhyay, U. and A. Biswas (1996). Delayed response in randomized play-the-winner rule: a decision theoretic outlook. Calcutta Statistical Association Bulletin 46, 69–88.
35. Bandyopadhyay, U. and A. Biswas (1997a). Sequential comparison of two treatments in clinical trials: a decision theoretic approach based on randomized play-the-winner rule. Sequential Analysis 16, 65–91.
36. Bandyopadhyay, U. and A. Biswas (1997b). Some sequential tests in clinical trials based on randomized play-the-winner rule. Calcutta Statistical Association Bulletin 47, 67–89.
37. Bandyopadhyay, U. and A. Biswas (1999). Allocation by randomized play-the-winner rule in the presence of prognostic factors. Sankhya Series B 61, 397–412.
38. Bandyopadhyay, U. and A. Biswas (2000). Some sequential-type conditional tests in clinical trials based on generalized randomized play-the-winner rule. Metron 58, 187–200.
39. Bandyopadhyay, U. and A. Biswas (2001). Adaptive designs for normal responses with prognostic factors. Biometrika 88, 409–419.
40. Bandyopadhyay, U. and A. Biswas (2002a). Selection procedures in multi-treatment clinical trials. Metron 60, 143–157.
41. Bandyopadhyay, U. and A. Biswas (2002b). Test of Bernoulli success probability in inverse sampling for nearer alternatives using adaptive allocation. Statistica Neerlandica 56, 387–399.
42. Bandyopadhyay, U. and A. Biswas (2003). Nonparametric group sequential designs in randomized clinical trials. Australian and New Zealand Journal of Statistics 45, 367–376.
43. Bandyopadhyay, U. and A. Biswas (2004). An adaptive allocation for continuous response using Wilcoxon-Mann-Whitney score. Journal of Statistical Planning and Inference 123, 207–224.
44. Bandyopadhyay, U., A. Biswas, and R. Bhattacharya (2009a). Drop-the-loser design in the presence of covariates. Metrika 69, 1–15.
45. Bandyopadhyay, U., A. Biswas, and R. Bhattacharya (2009b). Kernel based response-adaptive design for continuous responses. Communications in Statistics Theory and Methods, Special Issue: Zacks Festschrift 39, 2691– 2705.
46. Bandyopadhyay, U., A. Biswas, and R. Bhattacharya (2010). A covariate adjusted adaptive design for two-stage clinical trials with survival data. Statistica Neerlandica 64, 202–226.
47. Bandyopadhyay, U., A. Biswas, and R. Bhattacharya (2011). A new response-adaptive design for continuous treatment responses for phase III clinical trials. Journal of Statistical Planning and Inference 141, 2256–2265.
48. Bartlett, R. H., D. W. Roloff, R. G. Cornell, A. F. Andrews, P. W. Dillon, and J. B. Zwischenberger (1985). Extracorporeal circulation in neonatal respiratory failure: A prospective randomized trial. Pediatrics 76, 479– 487.
49. Basak, G. K., A. Biswas, and S. Volkov (2008). An urn model and the odds ratio-based design for clinical trials. Markov Processes and Related Fields 14, 571–582.
50. Basak, G. K., A. Biswas, and S. Volkov (2009). An urn model for odds ratio based adaptive phase III clinical trials. Journal of Biopharmaceutical Statistics 19, 838–856.
51. Bather, J. A. (1985). On the allocation of treatments in sequential medical trials (with discussion). International Statistical Review 53, 1–14.
52. Bauer, M., P. Bauer, and M. Buddle (1994). A simulation program for adaptive two stage designs. Computational Statistics & Data Analysis 26, 351–371.
53. Bauer, P., W. Brannath, and M. Posch (2001). Flexible two-stage designs: an overview. Methods of Information in Medicine 40, 117–121.
54. Begg, C. B. (1990). On inference from Wei’s biased coin design for clinical trials (with discussion). Biometrika 77, 467–484.
55. Behrens, W. V. (1929). Ein Beitrag zur Fehlerberechnung bei wenigen Beobachtungen. Landwirtschaftliche Jahrbücher 68, 807–837.
56. Berger, J. O. (1985). Statistical Decision Theory and Bayesian Analysis, 2nd edn. New York: Springer-Verlag.
57. Berger, M. and W. K. Wong (2009). An Introduction to Optimal Designs for Social and Biomedical Research. New York: Wiley.
58. Berry, D. A. and M. Sobel (1973). An improved procedure for selecting the better of two binomial populations. Journal of the American Statistical Association 68, 979–984.
59. Berry, D. A. and D. Strangl (1996). Bayesian Biostatistics. New York: Marcel Dekker.
60. Berry, S. M., B. P. Carlin, J. J. Lee, and P. Müller (2011). Bayesian Adaptive Methods for Clinical Trials. Boca Raton: Chapman and Hall/ CRC Press.
61. Biswas, A. (1996). Some Sequential-type Nonparametrics in Clinical Trials. Ph. D. thesis, Department of Statistics, University of Calcutta, India.
62. Biswas, A. (1999a). Delayed response in randomized play-the-winner rule revisited. Communication in Statistics, Simulation and Computation 28, 715–731.
63. Biswas, A. (1999b). Optimal choice of design parameter in an adaptive design. Technical Report ASD/99/10, Applied Statistics Unit, Indian Statistical Institute, India.
64. Biswas, A. (1999c). Stopping rule in delayed response randomized play-the-winner rule. REBRAPE, Brazilian Journal of Probability and Statistics (Revista Brasileira de Probabilidade e Estatistica) 13, 95–110.
65. Biswas, A. and J. F. Angers (2002). A Bayesian adaptive design in clinical trials for continuous responses. Statistica Neerlandica 56, 400–414.
66. Biswas, A. and A. Basu (2001). Robust adaptive designs in clinical trials for continuous responses. Sankhya Series B 63, 27–42.
67. Biswas, A. and R. Bhattacharya (2009). Optimal response-adaptive designs for normal responses. Biometrical Journal 51, 193–202.
68. Biswas, A. and R. Bhattacharya (2010). An optimal response-adaptive design with dual constraints. Statistics and Probability Letters 80, 177–185.
69. Biswas, A. and R. Bhattacharya (2011). Treatment adaptive allocations in randomized clinical trials: an overview. In A. Pong and S.-C. Chow (Eds.), Handbook of Adaptive Designs in Pharmaceutical and Clinical Development, pp. 17:1–17:19. London: CRC Press.
70. Biswas, A. and R. Bhattacharya (2013). Near efficient target allocations in response-adaptive randomization. Statistical Methods in Medical Research 22. (In press).
71. Biswas, A., R. Bhattacharya, and L. Zhang (2007). Optimal response-adaptive designs for continuous responses in phase III trials. Biometrical Journal 49, 928–940.
72. Biswas, A. and M. Bose (2011). Multi-centre adaptive group sequential test. Technical report, Applied Statistics Unit, Indian Statistical Institute, Kolkota, India.
73. Biswas, A. and D. S. Coad (2005). A general multi-treatment adaptive design for multivariate responses. Sequential Analysis 24, 139–158.
74. Biswas, A. and A. Dewanji (2004a). An adaptive clinical trial with repeated monitoring for the treatment of rheumatoid arthritis. Australian and New Zealand Journal of Statistics 46, 675–684.
75. Biswas, A. and A. Dewanji (2004b). Inference for a RPW-type clinical trial with repeated monitoring for the treatment of rheumatoid arthritis. Biometrical Journal 46, 769–779.
76. Biswas, A. and A. Dewanji (2004c). Inference for a RPW-type clinical trial with repeated monitoring for the treatment of rheumatoid arthritis. Biometrical Journal 46, 769–779.
77. Biswas, A. and A. Dewanji (2004d). Sequential adaptive designs for clinical trials with longitudinal response. In N. Mukhopadhyay, S. Chattopad-hyay, and S. Datta (Eds.), Applied Sequential Methodologies, pp. 69–84. New York: Marcel Dekker, Inc.
78. Biswas, A. and S. Mandal (2004). Optimal adaptive designs in phase III clinical trials for continuous responses with covariates. In A. Di. Bucchianico, H. Läuter, and H. P. Wynn (Eds.), mODa7-Advances in Model-Oriented Design and Analysis, pp. 51–58. Heidelberg: Physica-Verlag.
79. Biswas, A. and S. Mandal (2007). Optimal three-treatment response-adaptive designs for phase III clinical trials with binary responses. In J. Lopez-Fidalgo, J. M. Rodriguez-Diaz, and B. Torsney (Eds.), mODa8 Advances in Model-Oriented Design and Analysis, pp. 33–40. Heidelberg: Physica-Verlag.
80. Biswas, A., S. Mandal, and R. Bhattacharya (2011). Multi-treatment optimal response-adaptive designs for phase III clinical trials. Journal of the Korean Statistical Society 40, 33–40.
81. Biswas, A. and P. Pal (2009). Intermediate monitoring, sample size reassessment and multi-treatment optimal response-adaptive designs for phase III clinical trials with more than one constraint. Communications in Statistics-Simulation and Computation 38, 1308–1320.
82. Biswas, A., E. Park, and R. Bhattacharya (2012). Covariate-adjusted response-adaptive designs for longitudinal treatment responses: PEMF trial revisited. Statistical Methods in Medical Research 21, 379–392.
83. Biswas, A. and J. N. K. Rao (2004). Missing responses in adaptive allocation design. Statistics and Probability Letters 70, 59–70.
84. Blackwell, D. and J. L. Hodges (1957). Design for the control of selection bias. Annals of Mathematical Statistics 28, 449–460.
85. Bonney, G. E. (1987). Logistic regression for dependent binary observations. Biometrics 43, 951–973.
86. Bornkamp, B., F. Bretz, H. Dette, and J. C. Pinheiro (2011). Response-adaptive dose-finding under model uncertainty. Annals of Applied Statistics 5, 1611–1631.
87. Box, G. E. P. and D. R. Cox (1964). An analysis of transformations (with discussion). Journal of the Royal Statistical Society, Series B 26, 211– 246.
88. Breslow, N. (1970). A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57, 579–594.
89. Bretz, F., H. Schmidli, F. König, A. Racine, and W. Maurer (2006). Confirmatory seamless phase II/III clinical trials with hypothesis selection at interim: General concepts. Biometrical Journal 48, 623–634.
90. Burman, C.-F. (1996). On Sequential Treatment Allocations in Clinical Trials. Göteborg: Department of Mathematics.
91. Byar, D. P., R. M. Simon, W. T. Friedewald, J. J. Schlesselman, D. L. DeMets, J. H. Ellenberg, M. H. Gail, and J. H. Ware (1976). Randomized clinical trials – perspectives on some recent ideas. New England Journal of Medicine 295, 74–80.
92. Chen, Y. P. (1999). Biased coin design with imbalance tolerance. Communications and Statistics-Stochastic Models 15, 953–975.
93. Chen, Y. P. (2000). Which design is better? Ehrenfest urn versus biased coin. Advances in Applied Probability 32, 738–749.
94. Chow, S. C. and M. Chang (2012). Adaptive Design Method in Clinical Trials, 2nd edn. Boca Raton: Chapman and Hall/CRC Press.
95. Chow, S.-C. and J. Shao (2002). Statistics in Drug Research: Methodologies and Recent Developments. New York: Marcel Dekker.
96. Coad, D. S. (1992). Some results on estimation for two stage clinical trials. Sequential Analysis 11, 299–311.
97. Coad, D. S. (1994). Sequential estimation for two-stage and three-stage clinical trials. Journal of Statistical Planning and Inference 43, 343–351.
98. Cochran, W. G. (1977). Sampling Techniques, 3rd edn. New York: Wiley.
99. Colton, T. (1963). A model for selecting one of two medical treatments. Journal of the American Statistical Association 58, 388–401.
100. Connor, E. M., R. S. Sperling, R. Gelber, P. Kiselev, G. Scott, M. J. O’Sullivan, R. Vandyke, M. Bey, W. Shearer, R. l. Jacobson, E. Jiminez, E. O’Neill, B. Bazin, J. Delfraissy, M. Culname, R. Coombs, M. Elkins, J. Moye, P. Stratton, J. Balsey, and (Report written for the Pediatric AIDS Clinical Trial Group Protocol 076 Study Group) (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine 331, 1173–1180.
101. Cornell, R. G., B. D. Landenberger, and R. H. Bartlett (1986). Randomized play-the-winner clinical trials (with discussion). Communications in Statistics, Series A 15, 159–178.
102. Cox, D. R. (1951). Some systematic experimental designs. Biometrika 38, 312–323.
103. Cox, D. R. (1982a). Randomization and concomitant variables in the design of experiments. In G. Kallianpur, J. K. Krishnaiah, and J. K. Ghosh (Eds.), Statistics and Probability: Essays in Honor of C. R. Rao, pp. 197–202. Amsterdam: North-Holland.
104. Cox, D. R. (1982b). A remark on randomization in clinical trials. Utilitas Mathematica 21A, 245–252.
105. DeMets, D. L., C. D. Furberg, and L. M. Friedman (Eds.) (2006). Data Monitoring in Clinical Trials: A Case Studies Approach, New York. Springer-Verlag.
106. Dette, H., B. Bornkamp, and F. Bretz (2013). On the efficiency of two-stage response-adaptive designs. Statistics in Medicine 32, 1646–1660.
107. Dumville, J. C., S. Hahn, J. N. V. Miles, and D. J. Torgerson (2006). The use of unequal randomisation ratios in clinical trials: a review. Contemporary Clinical Trials 27, 1–12. doi:10.1016/j.cct.2005.08.003.
108. Durham, S. D., N. Flournoy, and W. Li (1998). Sequential designs for maximizing the probability of a favorable response. Canadian Journal of Statistics 3, 479–495.
109. Durham, S. D. and C. F. Yu (1990). Randomized play-the-leader rules for sequential sampling from two populations. Probability in the Engineering and Informational Sciences 4, 355–367.
110. Dworkin, R. H., A. E. Corbin, J. P. Young, U. Sharma, L. LaMoreaux, H. Bockbrader, E. A. Garofalo, and R. M. Poole (2003). Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology 60, 1274–1283.
111. Efron, B. (1971). Forcing a sequential experiment to be balanced. Biometrika 58, 403–417.
112. Eggenberger, F. and G. Pólya (1923). Über die Statistik verketteter Vorgänge. Zeitschrift fur Angewandte Mathematik und Mechanik 3, 279– 289.
113. Eisele, J. R. (1990). An adaptive biased coin design for the Behrens-Fisher problem. Sequential Analysis 9, 343–359.
114. Eisele, J. R. (1994). The doubly adaptive biased coin design for sequential clinical trials. Journal of Statistical Planning and Inference 38, 249–262.
115. Eisele, J. R. and M. Woodroofe (1995). Central limit theorems for doubly adaptive biased coin designs. Annals of Statistics 23, 234–254.
116. Ellenberg, S. S., T. R. Fleming, and D. L. DeMets (2002). Data Monitoring Committees in Clinical Trials: A Practical Perspective. London: Wiley.
117. Everitt, B. S. and A. Pickles (2004). Statistical Aspects of the Design and Analysis of Clinical Trials, Revised edn. London: Imperial College Press.
118. Faries, D. E., R. N. Tamura, and J. S. Andersen (1995). Adaptive designs in clinical trials: Lilly experience (with discussion). Biopharmaceutical Report 3, 1–11.
119. Fedorov, V. V. (1971). The design of experiments in the multiresponse case. Theory of Probability and its Applications 16, 323–332.
120. Fedorov, V. V. and P. Hackl (1997). Model-Oriented Design of Experiments. Lecture Notes in Statistics 125. New York: Springer-Verlag.
121. Fedorov, V. V. and S. L. Leonov (2014). Optimal Design for Nonlinear Response Models. Boca Raton: Chapman and Hall/ CRC Press.
122. Feller, W. (1971). An Introduction to Probability Theory and Its Applications Vol.1, 3rd edn. New York: Wiley.
123. Field, C. and B. Smith (1994). Robust estimation – a weighted maximum likelihood approach. International Statistical Review 62, 405–424.
124. Fisher, R. A. (1935). The fiducial argument in statistical inference. Annals of Eugenics 8, 391–398.
125. Fligner, M. A. and G. E. Policello (1981). Robust rank procedures for the Behrens-Fisher problem. Journal of the American Statistical Association 76, 162–168.
126. Fligner, M. A. and S. W. Rust (1982). A modification of Mood’s median test for the generalized Behrens-Fisher problem. Biometrika 69, 221–226.
127. Freedman, D. A. (1965). Bernard Friedman’s urn. Annals of Mathematical Statistics 65, 956–970.
128. Friedman, L. M., C. D. Furberg, and D. L. DeMets (2010). Fundamentals of Clinical Trials, 4th edn. New York: Springer-Verlag.
129. Fu, X., Z. Shen, Y. Chen, J. Xie, Z. Guo, M. Zhang, and Z. Sheng (1998). Randomized placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns. Lancet 352, 1661– 1663.
130. Fushimi, M. (1973). An improved version of a Sobel-Weiss play-the-winner procedure for selecting the better of two binomial populations. Biometrika 60, 517–523.
131. Gehan, E. A. (1965a). A generalized two-sample Wilcoxon test for doubly censored data. Biometrika 52, 650–653.
132. Gehan, E. A. (1965b). A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52, 203–223.
133. Goos, P. and B. Jones (2011). Optimal Design of Experiments: A Case Study Approach. New York: Wiley.
134. Hallstrom, A. L., M. M. Brooks, and M. Peckova (1996). Logrank, play the winner, power and ethics. Statistics in Medicine 15, 2135–2142.
135. Hampel, F. R., E. M. Ronchetti, P. J. Rousseeuw, and W. A. Stahel (1986). Robust Statistics: The Approach Based on Influence Functions. New York: Wiley.
136. Hardwick, J. P. (1995). A modified bandit as an approach to ethical allocation in clinical trials. In N. Flournoy and W. F. Rosenberger (Eds.), Adaptive Designs, pp. 65–87. Hayward, CA: Institute of Mathematical Statistics.
137. Hardwick, J. P. and Q. F. Stout (1995). Exact computational analyses for adaptive designs. In N. Flournoy and W. F. Rosenberger (Eds.), Adaptive Designs, pp. 223–237. Hayward, CA: Institute of Mathematical Statistics.
138. Harris, T. E. (1989). The Theory of Branching Processes. New York: Dover.
139. Hayre, L. S. (1979). Two-population sequential tests with three hypotheses. Biometrika 66, 465–474.
140. Hoel, D. G. (1972). An inverse stopping rule for play-the-winner sampling. Journal of the American Statistical Association 67, 148–151.
141. Hoel, D. G. and M. Sobel (1971). Comparison of sequential procedures for selecting the best binomial population. In L. M. Cam, J. Neyman, and E. Scott (Eds.), Proceedings of the Sixth Berkeley Symposium on Mathematical Statistics and Probability, IV, pp. 53–69. Berkeley, CA: University of California Press.
142. Holford, N., S. C. Ma, and B. A. Ploeger (2010). Clinical trial simulation: A review. Clinical Pharmacology and Therapeutics 88, 166–182.
143. Hu, F. and W. F. Rosenberger (2003). Optimality, variability, power: evaluating response-adaptive randomization procedures for treatment comparisons. Journal of the American Statistical Association 98, 671–678.
144. Hu, F. and W. F. Rosenberger (2006a). The Theory of Response-Adaptive Randomization in Clinical Trials. New York: Wiley.
145. Hu, F. and W. F. Rosenberger (2006b). The Theory of Response-Adaptive Randomization in Clinical Trials. New York: Wiley.
146. Hu, F., W. F. Rosenberger, and L.-X. Zhang (2006). Asymptotically best response-adaptive randomization procedures. Journal of Statistical Planning and Inference 136, 1911–1922.
147. Hu, F. and L.-X. Zhang (2004). Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials. Annals of Statistics 32, 268–301.
148. Hu, F., L. X. Zhang, and X. He (2009). Efficient randomized-adaptive designs. Annals of Statistics 37, 2543–2560.
149. Iglewicz, B. (1983). Alternative designs: sequential, multi-stage, decision theory and adaptive designs. In M. E. Buyse, J. Staquet, and R. J. Sylvester (Eds.), Cancer Clinical Trials: Methods and Practice, pp. 312– 334. Oxford: Oxford University Press.
150. Ivanova, A. (2003). A play-the-winner-type urn design with reduced variability. Metrika 58, 1–13.
151. Ivanova, A., A. Biswas, and H. Lurie (2006). Response adaptive designs for continuous outcomes. Journal of Statistical Planning and Inference 136, 1845–1852.
152. Ivanova, A. and S. D. Durham (2000). Drop the loser rule. Technical Report TR-00-01, University of North Carolina, Chapel Hill, NC.
153. Ivanova, A. and N. Flournoy (2001). A birth and death urn for ternary outcomes: stochastic processes applied to urn models. In C. A. Charalambides, M. V. Koutras, and N. Balakrishnan (Eds.), Probability and Statistical Models with Applications, pp. 583–600. Boca Raton: Chapman and Hall/CRC Press.
154. Ivanova, A., W. F. Rosenberger, S. D. Durham, and N. Flournoy (2000). A birth and death urn for randomized clinical trials. Sankhya, Series B 62, 104–118.
155. Jennison, C. and B. W. Turnbull (1993). Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses. Biometrics 49, 31–43.
156. Jennison, C. and B. W. Turnbull (2000). Group Sequential Methods with Applications to Clinical Trials. Boca Raton: Chapman and Hall/CRC Press.
157. Jennison, C. and B. W. Turnbull (2001). Group sequential tests with outcome-dependent treatment assignment. Sequential Analysis 20, 209– 234.
158. Johnson, N. L. and S. Kotz (1977). Urn Models and Their Application: An Approach to Modern Discrete Probability Theory. New York: Wiley.
159. Jones, S. E., J. Erban, B. Overmoyer, G. T. Budd, L. Hutchins, E. Lower, L. Laufman, S. Sundaram, W. J. Urba, K. I. Pritchard, R. Mennel, D. Richards, S. Olsen, M. L. Meyers, and P. M. Ravdin (2005). Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. Journal of Clinical Oncology 24, 5542–5551.
160. Kadane, J. B. (1994). An application of robust Bayesian analysis to a medical experiment. Journal of Statistical Planning and Inference 40, 221–232.
161. Kadane, J. B. (1995). Prime time for Bayes. Clinical Trials 16, 313–318.
162. Kadane, J. B. (1996). Bayesian Methods and Ethics in a Clinical Trial Design. New York: Wiley.
163. Kadane, J. B. and L. J. Wolfson (1996). Prior for the design and analysis of clinical trials. In D. Berry and D. Stangl (Eds.), Bayesian Biostatistics, pp. 157–184. New York: Marcel Dekker.
164. Karrison, T. G., D. Huo, and R. Chappell (2003). A group sequential, response-adaptive design for randomized clinical trials. Controlled Clinical Trials 24, 506–522.
165. Kiefer, J. (1959). Optimum experimental designs (with discussion). Journal of the Royal Statistical Society, Series B 21, 272–319.
166. Kiefer, J. and J. Wolfowitz (1960). The equivalence of two extremum problems. Canadian Journal of Mathematics 12, 363–366.
167. Kiefer, J. E. and G. H. Weiss (1974). Truncated version of a play-the-winner rule for choosing the better of two binomial populations. Journal of the American Statistical Association 69, 807–809.
168. Kimko, H. H. C. and C. C. Peck (2010). Clinical Trial Simulations: Applications and Trends. New York: Springer.
169. Krams, M., C.-F. Burman, V. Dragalin, B. Gaydos, A. P. Grieve, J. Pinheiro, and W. Maurer (2007). Adaptive designs in clinical drug development: opportunities, challenges, and scope. Journal of Biopharmaceutical Statistics 17, 957–964.
170. Krams, M., K. R. Lees, W. Hacke, A. P. Grieve, J.-M. Orgogozo, and G. A. Ford (2003). Acute stroke therapy by inhibition of neutrophils (ASTIN). An adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 34, 2543–2548.
171. Krams, M., A. Sharma, V. Dragalin, D. D. Burns, P. Fardipour, S. K. Padmanabhan, I. Perevozskaya, G. Littman, and R. Maguire (2009). Adaptive approaches in clinical drug development. Pharmaceutical Medicine 23, 139–148.
172. Krishna, R. (2006). Dose Optimization in Drug Development. New York: Informa.
173. Kumar, S. and S. Jain (2004). Treatment of appendiceal mass: prospective, randomized clinical trial. Indian Journal of Gastroenterology 23, 165– 167.
174. Kuznetsova, O. M. and Y. Tymofyev (2012). Preserving the allocation ratio at every allocation with biased coin randomization and minimization in studies with unequal allocation. Statistics in Medicine 31, 701–723.
175. Lachin, J. M., J. Marks, L. J. Schoenfield, and The Protocol Committee and The NCGS Group (1981). Design and methodological considerations in the national cooperative gallstone study: a multi-center clinical trial. Controlled Clinical Trials 2, 177–230.
176. Lai, T. Z. and C. Z. Wei (1982). Least squares estimates in stochastic regression models with applications to identification and control of dynamic systems. Annals of Statistics 10, 154–166.
177. Lan, K. K. G. and D. L. DeMets (1983). Discrete sequential boundaries for clinical trials. Biometrika 70, 649–663.
178. Lawrence, J. (2002). Strategies for changing the test statistic during a clinical trial. Journal of Biopharmaceutical Statistics 12, 193–205.
179. Li, W. (1995). Sequential Designs for Opposing Failure Functions. Ph. D. thesis, College of Arts and Sciences. American Univ., Washington DC.
180. Li, W., S. D. Durham, and N. Flournoy (1996). Randomized Pólya urn designs. In Proceedings of the Biometric Section of the American Statistical Association, 1996, pp. 166–170. Washington: American Statistical Association.
181. Little, R. J. A. and D. B. Rubin (1987). Statistical Analysis with Missing Data. New York: Wiley.
182. Liu, Q. and G. Y. Chi (2001). On sample size and inference for two-stage adaptive designs. Biometrics 57, 172–177.
183. Liu, Q., M. A. Proschan, and G. W. Pledger (2002). A unified theory of two-stage adaptive designs. Journal of the American Statistical Association 97, 1034–1041.
184. Loo, H., J. Saiz-Ruiz, J. A. C. E. Costa e Silva, M. Ansseau, R. Herrington, A. Vaz-Serra, H. Dilling, and S. de Risio (1999). Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. Journal of Affective Disorders 56, 109–118.
185. Mahmoud, H. M. (2009). Pólya Urn Models. Boca Raton: Chapman & Hall/CRC.
186. Mann, H. B. and D. R. Whitney (1947). On a test of whether one of two random variables is stochastically larger than the other. Annals of Mathematical Statistics 18, 50–60.
187. Mantel, N. (1967). Ranking procedures for arbitrarily restricted observation. Biometrics 23, 65–78.
188. Markaryan, T. and W. F. Rosenberger (2010). Exact properties of Efron’s biased coin randomization procedure. Annals of Statistics 38, 1546–1567.
189. Maronna, R. A., D. R. Martin, and V. J. Yohai (2006). Robust Statistics: Theory and Methods. New York: Wiley.
190. Matthews, J. N. S. (2006). An Introduction to Randomized Controlled Clinical Trials, 2nd edn. London: Edward Arnold.
191. Matthews, P. C. and W. F. Rosenberger (1997). Variance in randomized play-the-winner clinical trials. Statistics and Probability Letters 35, 233– 240.
192. McCullagh, P. and J. A. Nelder (1989). Generalized Linear Models, 2nd edn. London: Chapman and Hall.
193. McIntyre, R. S., D. A. Mancini, S. McCann, J. Srinivasan, D. Sagman, and S. H. Kennedy (2002). Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disorders 4, 207–213.
194. McPherson, K. (1974). Statistics: the problem of examining accumulating data more than once. New England Journal of Medicine 290, 501–502.
195. Melfi, V. and C. Page (2000). Estimation after adaptive allocation. Journal of Statistical Planning and Inference 87, 353–363.
196. Melfi, V., C. Page, and M. Geraldes (2001). An adaptive randomized design with application to estimation. The Canadian Journal of Statistics 29, 107–116.
197. Morgan, C. C. (2003a). Estimation following group-sequential response-adaptive clinical trials. Controlled Clinical Trials 24, 523–543.
198. Morgan, C. C. (2003b). Sample size re-estimation in group-sequential response-adaptive clinical trials. Statistics in Medicine (Papers from the International Meetings of the International Society for Clinical Bio-statistics) 22, 3843–3857.
199. Müller, C. H. (1997). Robust Planning and Analysis of Experiments. Lecture Notes in Statistics 124. Berlin: Springer-Verlag.
200. Nordbrock, E. (1976). An improved play-the-winner sampling procedure for selecting the better of two binomial populations. Journal of the American Statistical Association 71, 137–139.
201. O’Brien, P. C. and T. R. Fleming (1979). A multiple testing procedure for clinical trials. Biometrics 35, 549–556.
202. Palmer, C. R. and W. F. Rosenberger (1999). Ethics and practice: Alternative designs for phase III randomized clinical trials. Controlled Clinical Trials 20, 172–186.
203. Parmar, M. K. B., D. J. Spiegelhalter, and L. S. Freedman (1994). The chart trials: Bayesian design and monitoring in practice. Statistics in Medicine 36, 1297–1312.
204. Pázman, A. (1986). Foundations of Optimum Experimental Design. Dor-drecht: Reidel.
205. Piantadosi, S. (2005). Clinical Trials: A Methodologic Perspective, 2nd edn. New York: Wiley.
206. Pocock, S. J. (1977). Group sequential methods in design and analysis of clinical trials. Biometrika 64, 191–199.
207. Pocock, S. J. (1983). Clinical Trials: a Functional Approach. New York: Wiley.
208. Pocock, S. J. and R. Simon (1975). Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31, 103–115.
209. Pong, A. and S.-C. Chow (2010). Handbook of Adaptive Designs in Pharmaceutical and Clinical Development. Boca Raton: Chapman & Hall/CRC Press.
210. Posch, M. and P. Bauer (1999). Adaptive two stage designs and the conditional error function. Biometrical Journal 41, 689–696.
211. Pronzato, L. (2010). Penalized optimal designs for dose-finding. Journal of Statistical Planning and Inference 140, 283–296.
212. Pronzato, L. and A. Pázman (2013). Design of Experiments in Nonlinear Models. New York: Springer.
213. Proschan, M. A. and S. A. Hunsberger (1995). Designed extension of studies based on conditional power. Biometrics 51, 1315–1324.
214. Proschan, M. A., Q. Liu, and S. Hunsberger (2003). Practical midcourse sample size modification in clinical trials. Controlled Clinical Trials 24, 4–15.
215. Pukelsheim, F. (1993). Optimal Design of Experiments. New York: Wiley.
216. Reiger, D. A., J. K. Myers, M. Kramer, L. N. Robins, D. G. Blazer, R. L. Hough, W. W. Eaton, and B. Z.. Locke (1984). The NIMH epidemiologic catchment area program. Archives of General Psychiatry 41, 934–991.
217. Riani, M., A. C. Atkinson, and D. Perrotta (2013?). A parametric framework for the comparison of methods of very robust regression. Statistical Science 28. (To appear).
218. Robbins, H. (1952). Some aspects of the sequential design of experiments. Bulletin of the American Mathematical Society 58, 527–535.
219. Roberts, K. B., N. Urdaneta, R. Vera, and others (2000). Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix. International Journal of Cancer 90, 206–223.
220. Rosenberger, W. F. (1993). Asymptotic inference with response-adaptive treatment allocation designs. Annals of Statistics 21, 2098–2107.
221. Rosenberger, W. F. (1996). New directions in adaptive designs. Statistical Science 11, 137–149.
222. Rosenberger, W. F. (1999). Randomized play-the-winner clinical trials: review and recommendations. Controlled Clinical Trials 20, 328–342.
223. Rosenberger, W. F., N. Flournoy, and S. Durham (1997). Asymptotic normality of maximum likelihood estimators from multiparameter response-driven designs. Journal of Statistical Planning and Inference 60, 69–76.
224. Rosenberger, W. F. and F. Hu (2004). Maximizing power and minimizing treatment failures in clinical trials. Clinical Trials 1, 141–147.
225. Rosenberger, W. F. and J. L. Lachin (2002a). Randomization in Clinical Trials: Theory and Practice. New York: Wiley.
226. Rosenberger, W. F. and J. L. Lachin (2002b). Randomization in Clinical Trials: Theory and Practice. New York: Wiley.
227. Rosenberger, W. F. and P. Seshaiyer (1997). Adaptive survival trials. Journal of Biopharmaceutical Statistics 7, 617–624.
228. Rosenberger, W. F., N. Stallard, A. Ivanova, C. N. Harper, and M. L. Ricks (2001). Optimal adaptive designs for binary response trials. Biometrics 57, 173–177.
229. Rosenberger, W. F. and O. Sverdlov (2008). Handling covariates in the design of clinical trials. Statistical Science 23, 404–419.
230. Rosenberger, W. F., A. N. Vidyashankar, and D. K. Agarwal (2001). Covariate adjusted response adaptive designs for binary responses. Journal of Biopharmaceutical Statistics 11, 227–236.
231. Rout, C. C., D. A. Rocke, J. Levin, E. Gouws, and D. Reddy (1993). A reevaluation of the role of crystalloid preload in the prevention of hy-potension associated with spinal anesthesia for elective cesarean section. Anesthesiology 79, 262–269.
232. Royall, R. M. (1991). Ethics and statistics in randomized clinical trials (with discussion). Statistical Science 6, 52–62.
233. Scarborough, J. (1966). Numerical Mathematical Analysis, 6th edn. New Delhi: Oxford and IBH Publishing Co. Pvt. Ltd.
234. Seibold, J. R., J. H. Korn, R. Simms, and others (2000). Recombinant human relaxin in the treatment of scleroderma-a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine 132, 871–879.
235. Senn, S., D. Amin, R. A. Bailey, S. M. Bird, B. Bogacka, P. Colman, A. Garrett, A. Grieve, and P. Lachmann (2007). Statistical issues in first-in-man studies. Journal of the Royal Statistical Society, Series A 170, 517–579.
236. Senn, S. J. (1997). Statistical Issues in Drug Development. Chichester: Wiley.
237. Shao, J., Y. Yu, X., and B. Zhong (2010). A theory for testing hypotheses under covariate-adaptive randomization. Biometrika 97, 347–360.
238. Silverstone, T. (2001). Moclobemide vs. imipramine in bipolar depression: A multicentre double-blind clinical trial. Acta Psychiatrica Scandinav-ica 104, 104–109.
239. Silvey, S. D. (1980). Optimum Design. London: Chapman and Hall.
240. Simon, N. and R. Simon (2103). Adaptive enrichment designs for clinical trials. Biostatistics 14, 613–625. doi: 10.1093/biostatistics/kxt010.
241. Simons, G. (1986). Bayes rules for a clinical trials model with dichotomous responses. Annals of Statistics 14, 954–970.
242. Slud, E. V. (2005). Staggered entry. In P. Armitage and T. Colton (Eds.), Encyclopedia of Biostatistics, 2nd edn. New York: Wiley.
243. Smith, K. (1918). On the standard deviations of adjusted and interpolated values of an observed polynomial function and its constants and the guidance they give towards a proper choice of the distribution of observations. Biometrika 12, 1–85.
244. Smith, R. L. (1984a). Properties of biased coin designs in sequential clinical trials. Annals of Statistics 12, 1018—1034.
245. Smith, R. L. (1984b). Sequential treatment allocation using biased coin designs. Journal of the Royal Statistical Society, Series B 46, 519—543.
246. Smythe, R. T. (1996). Central limit theorems for urn models. Stochastic Processes and Their Applications 65, 115–137.
247. Soares, J. F. and C. F. J. Wu (1982). Some restricted randomization rules in sequential designs. Communications in Statistics-Theory and Methods 12, 2017–2034.
248. Sobel, M. and G. H. Weiss (1969). Play-the-winner rule and inverse sampling for selecting the best of k ≥ 3 binomial populations. Technical Report 126, University of Minnesota, Department of Statistics, Minneapolis, MN.
249. Sobel, M. and G. H. Weiss (1970). Play-the-winner rule and inverse sampling in selecting the better of two binomial populations. Biometrika 57, 357– 365.
250. Sobel, M. and G. H. Weiss (1971a). A comparison of play-the-winner and vector-at-a-time sampling for selecting the better of two binomial populations with restricted parameter values. Trabajos de Estadistica y de Investigation Operativa 22, 195–206.
251. Sobel, M. and G. H. Weiss (1971b). Play-the-winner rule and inverse sampling in selecting the better of two binomial populations. Journal of the American Statistical Association 66, 545–551.
252. Sobel, M. and G. H. Weiss (1972). Recent results on using play the winner sampling rule with binomial selection problems. In L. M. Le Cam, J. Neyman, and E. L. Scott (Eds.), Proceedings of the Sixth Berkeley Symposium on Mathematical Statistics and Probability, I, pp. 717–736. Berkeley, CA: University of California Press.
253. Spiegelhalter, D. J., K. R. Abrams, and J. P. Myles (2004). Bayesian Approaches to Clinical Trials and Health-care Evaluation. Chichester: Wiley.
254. Spiegelhalter, D. J., L. S. Freedman, and M. K. B. Parmar (1994). Bayesian approaches to randomized trials. Journal of the Royal Statistical Society Series A 157, 357–416.
255. Stallard, N. and W. F. Rosenberger (2001). Exact group-sequential designs for clinical trials with randomized play-the-winner allocation. Statistics in Medicine 21, 467–480.
256. Stallard, N. and S. Todd (2003). Sequential designs for phase III clinical trials incorporating treatment selection. Statistics in Medicine 22, 689–703.
257. Sutradhar, B. C., A. Biswas, and W. Bari (2005). Marginal regression for binary longitudinal data in adaptive clinical trials. Scandinavian Journal of Statistics 32, 93–114.
258. Sutradhar, B. C. and V. Jowaheer (2006). Analyzing longitudinal count data from adaptive clinical trials: a weighted generalized quasi-likelihood approach. Journal of Statistical Computation and Simulation 76, 1079– 1093.
259. Sverdlov, O. and W. F. Rosenberger (2013). Randomization in clinical trials: can we eliminate bias? Clinical Trial Perspective 3, 37–47.
260. Sverdlov, O., W. F. Rosenberger, and Y. Ryezenik (2013). Utility of covariate-adjusted response-adaptive randomization in survival trials. Statistics in Biopharmaceutical Research 5, 38–53.
261. Sverdlov, O., Y. Tymofyeyev, and W. K. Wong (2011). Optimal response-adaptive randomized designs for multi-armed survival trials. Statistics in Medicine 30, 2890–2910.
262. Tamura, R., D. Faries, J. Andersen, and J. Heiligenstein (1994). A case study of an adaptive clinical trial in the treatment of out-patients with depressive disorder. Journal of the American Statistical Association 89, 768–776.
263. The Trials of Hypertension Prevention Collaborative Research Group (1992). The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Journal of the American Medical Association 267, 1213–1220.
264. Thompson, W. R. (1933). On the likelihood that one unknown probability exceeds another in view of the evidence of two samples. Biometrika 25, 285–294.
265. Ting, N. (Ed.) (2006). Dose Finding in Drug Development, New York. Springer–Verlag.
266. Treasure, T. and K. D. MacRae (1999). Minimisation is much better than the randomised block design in certain cases. British Medical Journal 318, 1420.
267. Tweedie, M. C. K. (1957). Statistical properties of inverse Gaussian distributions. Annals of Mathematical Statistics 28, 362–377.
268. Tymofyeyev, Y., W. F. Rosenberger, and F. Hu (2007). Implementing optimal allocation in sequential binary response experiments. Journal of the American Statistical Association 102, 224–234.
269. Vieta, E., A. Martinez-Aran, J. M. Goikolea, C. Torrent, F. Colom, A. Ben-abarre, and M. Reinares (2002). A randomized trial comparing paroxe-tine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. Journal of Clinical Psychiatry 63, 508–512.
270. Ware, J. H. (1989). Investigating therapies of potentially great benefit: ECMO. Statistical Science 4, 298–340.
271. Ware, J. H. and M. F. Epstein (1985). Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 76, 849– 851.
272. Wei, L. J. (1977). A class of designs for sequential clinical trials. Journal of the American Statistical Association 72, 382–386.
273. Wei, L. J. (1978). On the random alllocation design for the control of selection bias in sequential experiments. Biometrika 65, 79–90.
274. Wei, L. J. (1979). The generalized Pólya’s urn for sequential medical trials. Annals of Statistics 7, 291–296.
275. Wei, L. J. (1988). Exact two-sample permutation tests based on the randomized play-the-winner rule. Biometrika 75, 603–606.
276. Wei, L. J. and S. Durham (1978). The randomized play-the-winner rule in medical trials. Journal of the American Statistical Association 73, 838–843.
277. Wei, L. J., R. T. Smythe, and R. L. Smith (1986). K-treatment compar-isons with restricted randomization rules in clinical trials. Annals of Statistics 14, 265–274.
278. Whitehead, J. (1997). The Design and Analysis of Sequential Clinical Trials, 2nd edn. Chichester: Wiley.
279. Wilcoxon, F. (1945). Individual comparisons by ranking methods. Biometrics 1, 80–83.
280. Wilson, T. W., Y. Lacourcière, and C. C. Barnes (1998). The antihyperten-sive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Medical Association Journal 159, 469–476.
281. Wong, W. K. and W. Zhu (2008). Optimum treatment allocation rules under a variance heterogeneity model. Statistics in Medicine 27, 4581–4595.
282. Yao, Q. and L. J. Wei (1996). Play the winner for phase II/III clinical trials. Statistics in Medicine 15, 2413–2423.
283. Zacks, S. (2009). Stage-Wise Adaptive Designs. New York: Wiley.
284. Zelen, M. (1969). Play-the-winner rule and the controlled clinical trial. Journal of the American Statistical Association 64, 131–146.
285. Zelen, M. and L. J. Wei (1995). Foreword. In N. Flournoy and W. F. Rosenberger (Eds.), Adaptive Designs. Hayward, CA: Institute of Mathematical Statistics.
286. Zeymer, U., H. Suryapranata, J. P. Monassier, Opolski, J. Davies, U. Ras-manis, G. Tebbe, R. Schröder, M. L. Willberg, R. Tiemann, T. Machnig, and K.-L. Neuhaus (2001). Evaluation of the safety and cardioprotec-tive effects of eniporide, a specific Sodium/Hydrogen exchange inhibitor, given as adjunctive therapy to reperfusion in patients with acute myocardial infarction. Heart Drug 1, 71–76.
287. + exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infraction. Journal of the American College of Cardiology 38, 1644–1651.
288. Zhang, L. and W. F. Rosenberger (2006a). Response-adaptive randomization for clinical trials with continuous outcomes. Biometrics 62, 562–569.
289. Zhang, L. and W. F. Rosenberger (2007a). Response-adaptive randomization for survival trials. Journal of the Royal Statistical Society, Series C 56, 153–165.
290. Zhang, L. and W. F. Rosenberger (2007b). Response-adaptive randomization for survival trials: the parametric approach. Applied Statistics 56, 153– 165.
291. Zhang, L. J. and W. F. Rosenberger (2006b). Response-adaptive randomization for clinical trials with continuous outcomes. Biometrics 62, 562–569.
292. Zhang, L. X. and F. Hu (2009). A new family of covariate-adjusted response adaptive designs and their properties. Applied Mathematics-A Journal of Chinese Universities 24, 1–13.
293. Zhang, L. X., F. Hu, and S. H. Cheung (2006). Asymptotic theorems of sequential estimation-adjusted urn models. Annals of Applied Probability 16, 340–369.
294. Zhang, L.-X., F. Hu, S. H. Cheung, and W. S. Chan (2007). Asymptotic properties of covariate-adjusted response-adaptive designs. Annals of Statistics 35, 1166–1182.
295. Zhu, H. and F. Hu (2010). Sequential monitoring of response-adaptive randomized clinical trials. Annals of Statistics 38, 2218–2241.